The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Identification of SARS-CoV-2 inhibitors using lung and colonic organoids
Open accessAbstract
There is an urgent need to create novel models using human disease-relevant cells to study severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) biology and to facilitate drug screening. Here, as SARS-CoV-2 primarily infects the respiratory tract, we developed a lung organoid model using human pluripotent stem cells (hPSC-LOs). The hPSC-LOs (particularly alveolar type-II-like cells) are permissive to SARS-CoV-2 infection, and showed robust induction of chemokines following SARS-CoV-2 infection, similar to what is seen in patients with COVID-19. Nearly 25% of these patients also have gastrointestinal manifestations, which are associated with worse COVID-19 outcomes 1. We therefore also generated complementary hPSC-derived colonic organoids (hPSC-COs) to explore the response of colonic cells to SARS-CoV-2 infection. We found that multiple colonic cell types, especially enterocytes, express ACE2 and are permissive to SARS-CoV-2 infection. Using hPSC-LOs, we performed a high-throughput screen of drugs approved by the FDA (US Food and Drug Administration) and identified entry inhibitors of SARS-CoV-2, including imatinib, mycophenolic acid and quinacrine dihydrochloride. Treatment at physiologically relevant levels of these drugs significantly inhibited SARS-CoV-2 infection of both hPSC-LOs and hPSC-COs. Together, these data demonstrate that hPSC-LOs and hPSC-COs infected by SARS-CoV-2 can serve as disease models to study SARS-CoV-2 infection and provide a valuable resource for drug screening to identify candidate COVID-19 therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“high-throughput screens of ≥1,000 drugs approved by the FDA run on colonic and lung organoids identified several SARS-CoV-2 entry inhibitors such as imatinib, mycophenolic acid and quinacrine dihydrochloride111.”
From Human disease models in drug development (2023) · cites this paper as [111]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“amodiaquine (for example, NCT04532931, NCT04502342)51 and imatinib111 (for example, NCT04394416) have entered clinical trials.”
From Human disease models in drug development (2023) · cites this paper as [111]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
Self-citationImbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Self-citationWebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs
Liao, Y., Wang, J., Jaehnig, E. J., Shi, Z., & Zhang, B. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz401 · Cited by 3,144
Cell entry mechanisms of SARS-CoV-2
Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., & Li, F. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003138117 · Cited by 3,142
Monteil, V., Kwon, H., Prado, P., Hagelkrüys, A., Wimmer, R. A., Stahl, M., Leopoldi, A., Garreta, E., Hurtado del Pozo, C., Prosper, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.004 · Cited by 2,122
Pan, L., Mu, M., Yang, P., Sun, Y., Wang, R., Yan, J., Li, P., Hu, B., Wang, J., Hu, C., et al. (2020) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000620 · Cited by 1,823
A molecular cell atlas of the human lung from single-cell RNA sequencing
Travaglini, K. J., Nabhan, A. N., Penland, L., Sinha, R., Gillich, A., Sit, R. V., Chang, S., Conley, S. D., Mori, Y., Seita, J., et al. (2020) · Nature · doi:10.1038/s41586-020-2922-4 · Cited by 1,730
Cited by
Sorted by citations
Evolution of antibody immunity to SARS-CoV-2
Gaebler, C., Wang, Z., Lorenzi, J. C. C., Muecksch, F., Finkin, S., Tokuyama, M., Cho, A., Jankovic, M., Schaefer-Babajew, D., Oliveira, T. Y., et al. (2021) · Nature · doi:10.1038/s41586-021-03207-w · Cited by 1,674
Self-citationHofer, M., & Lutolf, M. P. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00279-y · Cited by 1,184
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas
Müller, J. A., Groß, R. M., Conzelmann, C., Krüger, J., Merle, U., Steinhart, J., Weil, T., Koepke, L., Bozzo, C. P., Read, C., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00347-1 · Cited by 564
Human organoids in basic research and clinical applications
Tang, X.-Y., Wu, S., Wang, D., Chu, C., Hong, Y., Tao, M., Hu, H., Xu, M., Guo, X. L., & Liu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01024-9 · Cited by 539
Self-citationHuman disease models in drug development
Loewa, A., Feng, J. J., & Hedtrich, S. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00063-3 · Cited by 331
Potential intestinal infection and faecal–oral transmission of SARS-CoV-2
Guo, M., Tao, W., Flavell, R. A., & Zhu, S. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00416-6 · Cited by 314
Ruaro, B., Salton, F., Braga, L., WADE, B. E., Confalonieri, P., Volpe, M. C., Baratella, E., Maiocchi, S., & Confalonieri, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052566 · Cited by 346
Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19
Ahn, J. H., Kim, J., Hong, S. P., Choi, S. Y., Yang, M. J., Ju, Y. S., Kim, Y. T., Kim, H. M., Rahman, M. T., Chung, M. K., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148517 · Cited by 295
Organoids: The current status and biomedical applications
Yang, S., Hu, H., Kung, H., Zou, R.-Q., Dai, Y.-S., Hu, Y.-F., Wang, T., Lv, T., Yu, J., & Li, F. (2023) · MedComm · doi:10.1002/mco2.274 · Cited by 300
Three-Dimensional Cell Cultures: The Bridge between In Vitro and In Vivo Models
Urzì, O., Gasparro, R., Costanzo, E., Luca, A. D., Giavaresi, G., Fontana, S., & Alessandro, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512046 · Cited by 258
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection
Synowiec, A., Szczepański, A., Barreto-Durán, E., Lie, L. K., & Pyrć, K. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00133-20 · Cited by 228
Clinical applications of human organoids
Verstegen, M. M. A., Coppes, R. P., Béghin, A., Coppi, P. D., Gerli, M., de Graeff, N., Pan, Q., Saito, Y., Shi, S., ZADPOOR, A. A., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03489-3 · Cited by 230
Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2
Gu, Y., Cao, J., Zhang, X., Gao, H., Wang, Y., Wang, J., He, J., Jiang, X., Zhang, J., Shen, G., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00595-6 · Cited by 215
Aboul‐Soud, M. A. M., Alzahrani, A. J., & Mahmoud, A. (2021) · Cells · doi:10.3390/cells10092319 · Cited by 225
SARS-CoV-2 infection induces beta cell transdifferentiation
Tang, X., Uhl, S. A., Zhang, T., Xue, D., Li, B., Vandana, J. J., Acklin, J. A., Bonnycastle, L. L., Narisu, N., Erdos, M. R., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.05.015 · Cited by 196
Self-citationMucosal immune response in biology, disease prevention and treatment
Zhou, X., Wu, Y., Zhu, Z., Lu, C., Zhang, C., Zeng, L., Xie, F., Zhang, L., & Zhou, F. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02043-4 · Cited by 230
A roadmap to pulmonary delivery strategies for the treatment of infectious lung diseases
He, S., Gui, J., Xiong, K., Chen, M., Gao, H., & Fu, Y. S. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01307-x · Cited by 188
Hoagland, D. A., Møller, R., Uhl, S. A., Oishi, K., Frere, J. J., Golynker, I., Horiuchi, S., Panis, M., Blanco-Melo, D., Sachs, D. M., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.017 · Cited by 177
Self-citationTian, M., Wei, J., Lv, E., Li, C., Liu, G., Sun, Y., Yang, W., Wang, Q., Shen, C., Zhang, C., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.155355 · Cited by 177
Human organoids: New strategies and methods for analyzing human development and disease
Corsini, N. S., & Knoblich, J. A. (2022) · Cell · doi:10.1016/j.cell.2022.06.051 · Cited by 176
Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19
Tindle, C., Fuller, M., Fonseca, A. G., Taheri, S., Ibeawuchi, S., Beutler, N., Katkar, G. D., Claire, A., Castillo, V., Hernandez, M., et al. (2021) · eLife · doi:10.7554/elife.66417 · Cited by 156
Human organoid models to study SARS-CoV-2 infection
Han, Y., Yang, L., Lacko, L. A., & Chen, S. (2022) · Nature Methods · doi:10.1038/s41592-022-01453-y · Cited by 158
Self-citationOrganoids in gastrointestinal diseases: From experimental models to clinical translation
Günther, C., Winner, B., Neurath, M. F., & Stappenbeck, T. S. (2022) · Gut · doi:10.1136/gutjnl-2021-326560 · Cited by 145
Cell response analysis in SARS-CoV-2 infected bronchial organoids
Sano, E., Suzuki, T., Hashimoto, R., Itoh, Y., Sakamoto, A., Sakai, Y., Saito, A., Okuzaki, D., Motooka, D., Muramoto, Y., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03499-2 · Cited by 137
Tiwari, S. K., Wang, S., Smith, D. M., Carlin, A. F., & Rana, T. M. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.02.005 · Cited by 136
Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic
Oudit, G. Y., Wang, K., Viveiros, A., Kellner, M. J., & Penninger, J. M. (2023) · Cell · doi:10.1016/j.cell.2023.01.039 · Cited by 136
Human pluripotent-stem-cell-derived organoids for drug discovery and evaluation
Vandana, J. J., Manrique, C., Lacko, L. A., & Chen, S. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.04.011 · Cited by 135
Self-citationResearch Progress, Challenges, and Breakthroughs of Organoids as Disease Models
Huang, Y., Huang, Z., Tang, Z., Chen, Y., Huang, M., Liu, H., Huang, W., Ye, Q., & Jia, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.740574 · Cited by 134
Self-citationRecent advances in lung organoid development and applications in disease modeling
Vazquez‐Armendariz, A. I., & Tata, P. R. (2023) · Journal of Clinical Investigation · doi:10.1172/jci170500 · Cited by 136
Aman, J., Duijvelaar, E., Botros, L., Kianzad, A., Schippers, J. R., Smeele, P. J., Azhang, S., Bartelink, I. H., Bayoumy, A. A., Bet, P. M., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00237-x · Cited by 120
Inflammatory responses in the placenta upon SARS-CoV-2 infection late in pregnancy
Argueta, L. B., Lacko, L. A., Bram, Y., Tada, T., Carrau, L., Rendeiro, A. F., Zhang, T., Uhl, S. A., Lubor, B., Chandar, V., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104223 · Cited by 117
Self-citationNavigating the complexities of drug development for inflammatory bowel disease
Honap, S., Jairath, V., Danese, S., & Peyrin‐Biroulet, L. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00953-0 · Cited by 123
Current Strategies of Antiviral Drug Discovery for COVID-19
Mei, M., & Tan, X. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.671263 · Cited by 111
SARS-CoV-2 infection causes dopaminergic neuron senescence
Chen, S., Kim, T. W., Yang, L., Kim, T., Nair, M., Harschnitz, O., Wang, P., Zhu, J., Koo, S. Y., Tang, X., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2023.12.012 · Cited by 132
Self-citationGamage, A. M., Tan, K. S., Chan, W. O. Y., Liu, J., Tan, C. W., Ong, Y. K., Thong, M. K. T., Andiappan, A. K., Anderson, D. E., Wang, D. Y., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009130 · Cited by 107
Xiang, D., He, A., Zhou, R., Wang, Y., Xiao, X., Gong, T., Kang, W., Lin, X., Wang, X., Consortium11, P.-B. D., et al. (2024) · Theranostics · doi:10.7150/thno.96027 · Cited by 108
Self-citationSARS-CoV-2 Infection Induces Ferroptosis of Sinoatrial Node Pacemaker Cells
Han, Y., Zhu, J., Yang, L., Nilsson-Payant, B. E., Hurtado, R., Lacko, L. A., Sun, X., Gade, A. R., Higgins, C. A., Sisso, W. J., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.320518 · Cited by 106
Self-citationWang, S., Li, W., Wang, Z., Yang, W., Li, E., Xia, X., Yan, F., & Chiu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01917-x · Cited by 124
The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update
Azar, J. H., Bahmad, H. F., Daher, D., Moubarak, M. M., Hadadeh, O., Monzer, A., Bitar, S. A., Jamal, M., Al‐Sayegh, M., & Abou-Kheir, W. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147667 · Cited by 106
Microfluidic Organoids-on-a-Chip: Quantum Leap in Cancer Research
Düzağaç, F., Saorin, G., Memeo, L., Canzonieri, V., & Rizzolio, F. (2021) · Cancers · doi:10.3390/cancers13040737 · Cited by 97
A comprehensive review on 3D tissue models: Biofabrication technologies and preclinical applications
Xie, R., Pal, V., Yu, Y., Lu, X., Gao, M., Liang, S., Huang, M., Peng, W., & Ozbolat, I. T. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122408 · Cited by 105
Puhl, A. C., Fritch, E. J., Lane, T. R., Tse, L. V., Yount, B. L., Sacramento, C. Q., Rodrigues, N. F., Tavella, T. A., Costa, F. T. M., Weston, S. M., et al. (2021) · ACS Omega · doi:10.1021/acsomega.0c05996 · Cited by 82
Advanced human developmental toxicity and teratogenicity assessment using human organoid models
Li, M., Gong, J., Gao, L., Zou, T., Kang, J., & Xu, H. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113429 · Cited by 84
Rosa, R. B., Dantas, W. M., do Nascimento, J. C. F., da Silva, M. V., de Oliveira, R. N., & Pena, L. (2021) · Viruses · doi:10.3390/v13030379 · Cited by 89
Chiu, M. C., Li, C., Liu, X., Yu, Y., Huang, J., Wan, Z., Xiao, D., Chu, H., Cai, J., Zhou, B., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00422-1 · Cited by 85
COVID-19 drug discovery and treatment options
Chan, J. F., Yuan, S., Chu, H., Sridhar, S., & Yuen, K. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01036-y · Cited by 92
Lian, Q., Zhang, K., Zhang, Z., Duan, F., Guo, L., Luo, W., Mok, B. W.-Y., Thakur, A., Ke, X., Motallebnejad, P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29731-5 · Cited by 85
Self-citationAn Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts
Yang, L., Han, Y., Jaffré, F., Nilsson-Payant, B. E., Bram, Y., Wang, P., Zhu, J., Zhang, T., Redmond, D., Houghton, S., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.319060 · Cited by 83
Self-citationJamison, D. A., Narayanan, S. A., Trovão, N. S., Guarnieri, J. W., Topper, M. J., Moraes‐Vieira, P. M., Zaksas, V., Singh, K. K., Wurtele, E. S., & Beheshti, A. (2022) · European Journal of Human Genetics · doi:10.1038/s41431-022-01108-8 · Cited by 95
Organoid Models for Infectious Disease
Blutt, S. E., & Estes, M. K. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-042320-023055 · Cited by 81
Applications of human organoids in the personalized treatment for digestive diseases
Wang, Q., Guo, F., Jin, Y., & Ma, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01194-6 · Cited by 87
Recent advances in developing small-molecule inhibitors against SARS-CoV-2
Xiang, R., Yu, Z., Wang, Y., Wang, L., Huo, S., Li, Y., Liang, R., Hao, Q., Ying, T., Gao, Y., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.016 · Cited by 77
Li, S., Yang, S., Zhou, Y., Disoma, C., Dong, Z., Du, A., Zhang, Y., Chen, Y., Huang, W., Chen, J., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.712081 · Cited by 80
The Progress of Intestinal Epithelial Models from Cell Lines to Gut-On-Chip
Rahman, S., Ghiboub, M., Donkers, J. M., van de Steeg, E., van Tol, E. A. F., Hakvoort, T. B. M., & de Jonge, W. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413472 · Cited by 84
Swart, A. L., Laventie, B., Sütterlin, R., Junne, T., Lauer, L., Manfredi, P., Jakonia, S., Yu, X., Karagkiozi, E., Okujava, R., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01718-6 · Cited by 76
Chaturvedi, S., Vasen, G., Pablo, M., Chen, X., Beutler, N., Kumar, A. J., Tanner, E. J., Illouz, S. E. M., Rahgoshay, D., Burnett, J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.11.004 · Cited by 75
Lung organoids, useful tools for investigating epithelial repair after lung injury
Kong, J., Wen, S., Cao, W., Yue, P., Xu, X., Zhang, Y., Luo, L., Chen, T., Li, L., Wang, F., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02172-5 · Cited by 79
Li, C., Huang, J., Yu, Y., Wan, Z., Chiu, M. C., Liu, X., Zhang, S., Cai, J., Chu, H., Li, G., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2300376120 · Cited by 72
Microfluidic Organs-on-a-Chip for Modeling Human Infectious Diseases
Wang, Y., Wang, P., & Qin, J. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00411 · Cited by 69
Self-citationDuan, X., Tang, X., Nair, M. S., Zhang, T., Qiu, Y., Zhang, W., Wang, P., Huang, Y., Xiang, J., Wang, H., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109920 · Cited by 66
Self-citationEndothelial contribution to COVID-19: an update on mechanisms and therapeutic implications
Ma, Z., Yang, Y., Huang, Y., & Lui, K. O. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.11.010 · Cited by 70
Self-citationSARS-CoV-2 infects human adult donor eyes and hESC-derived ocular epithelium
Eriksen, A. Z., Møller, R., Makovoz, B., Uhl, S. A., tenOever, B. R., & Blenkinsop, T. A. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.04.028 · Cited by 105
Self-citationWagoner, J., Herring, S., Hsiang, T.-Y., Ianevski, A., Biering, S. B., Xu, S. B., Hoffmann, M., Pöhlmann, S., Gale, M., Aittokallio, T. A., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.03331-22 · Cited by 72
SARS-CoV-2 Infection of Airway Epithelial Cells
Ryu, G., & Shin, H. (2021) · Immune Network · doi:10.4110/in.2021.21.e3 · Cited by 74
Chan, L., Anderson, D. E., Cheng, H. S., Ivan, F. X., Chen, S., Zheng, A. K. E., Foo, R., Gamage, A. M., Tiew, P. Y., Koh, M. S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35253-x · Cited by 72
Self-citationModular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class
Rapp, M., Guo, Y., Reddem, E. R., Yu, J., Liu, L., Wang, P., Cerutti, G., Katsamba, P. S., Bimela, J. S., Bahna, F. A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108950 · Cited by 59
Self-citationCoagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry
Kastenhuber, E. R., Mercadante, M., Nilsson-Payant, B. E., Johnson, J. L., Jaimes, J. A., Muecksch, F., Weisblum, Y., Bram, Y., Chandar, V., Whittaker, G. R., et al. (2022) · eLife · doi:10.7554/elife.77444 · Cited by 61
Self-citationAdvances in Microfluidic Technologies in Organoid Research
Liu, H., Gan, Z., Qin, X., Wang, Y., & Qin, J. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302686 · Cited by 68
Pathophysiology of infection with SARS‐CoV ‐2— What is known and what remains a mystery
Sridhar, S., & Nicholls, J. M. (2021) · Respirology · doi:10.1111/resp.14091 · Cited by 64
Banach, B. B., Cerutti, G., Fahad, A. S., Shen, C., de Souza, M. O., Katsamba, P. S., Tsybovsky, Y., Wang, P., Nair, M. S., Huang, Y., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2021.109771 · Cited by 56
Self-citationRecent advances in human respiratory epithelium models for drug discovery
Yaqub, N., Wayne, G. J., Birchall, M., & Song, W. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107832 · Cited by 64
Krasemann, S., Dittmayer, C., von Stillfried, S. F., Meinhardt, J., Heinrich, F., Hartmann, K., Pfefferle, S., Thies, E., von Manitius, R., Aschman, T., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104193 · Cited by 57
Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2
Yang, L., Nilsson-Payant, B. E., Han, Y., Jaffré, F., Zhu, J., Wang, P., Zhang, T., Redmond, D., Houghton, S., Møller, R., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.07.012 · Cited by 77
Self-citationLi, Z., Peng, M., Chen, P., Liu, C., Hu, A., Zhang, Y., Peng, J., Liu, J., Li, Y., Li, W., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.008 · Cited by 57
Self-citationSARS-CoV-2 Infection and Lung Regeneration
Zhao, F., Ma, Q., Yue, Q., & Chen, H. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00188-21 · Cited by 58
Self-citationDu, X., Chen, Z., Li, Q., Yang, S., Jiang, L., Yang, Y., Li, Y., & Gu, Z. (2023) · Bio-Design and Manufacturing · doi:10.1007/s42242-022-00226-y · Cited by 57
Machine Learning Models Identify Inhibitors of SARS-CoV-2
Gawriljuk, V. O., Zin, P. P. K., Foil, D. H., Bernatchez, J., Beck, S., Beutler, N., Ricketts, J., Yang, L., Rogers, T., Puhl, A. C., et al. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00683 · Cited by 56
Self-citationCommon Genetic Variation in Humans Impacts In Vitro Susceptibility to SARS-CoV-2 Infection
Dobrindt, K., Hoagland, D. A., Seah, C., Kassim, B. S., O’Shea, C. P., Murphy, A., Iskhakova, M., Fernando, M. B., Powell, S. K., Deans, P. J. M., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.02.010 · Cited by 53
Self-citationAdvanced lung organoids for respiratory system and pulmonary disease modeling
Joo, H., Min, S., & Cho, S. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314241232502 · Cited by 66
Hu, C., Yang, S., Zhang, T., Ge, Y., Chen, Z., Zhang, J., Pu, Y., & Liang, G. (2024) · Environment International · doi:10.1016/j.envint.2024.108415 · Cited by 56
Self-citationAlveolar Type II Cells and Pulmonary Surfactant in COVID-19 Era
Čalkovská, A., Kolomaznik, M., & Čalkovský, V. (2021) · Physiological Research · doi:10.33549/physiolres.934763 · Cited by 55
Ma, J., liu, J., Gao, D., Li, X., Zhang, Q., Lv, L., Wang, Y., Li, J., Zhu, Y., Wu, Z., et al. (2022) · Advanced Science · doi:10.1002/advs.202104192 · Cited by 53
Artificial intelligence for drug repurposing against infectious diseases
Singh, A. (2024) · Artificial Intelligence Chemistry · doi:10.1016/j.aichem.2024.100071 · Cited by 60
Kiener, M., Roldán, N., Machahua, C., Sengupta, A., Geiser, T., Guenat, O. T., Funke-Chambour, M., Hobi, N., & Julio, M. K. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.644678 · Cited by 52
Advancing lung organoids for COVID-19 research
van der Vaart, J., Lamers, M. M., Haagmans, B. L., & Clevers, H. C. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.049060 · Cited by 50
Generation of Skin Organoids: Potential Opportunities and Challenges
Sun, H., Zhang, Y., & Li, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.709824 · Cited by 55
Organoid: a powerful tool to study lung regeneration and disease
Lu, T., Cao, Y., Zhao, P., Shen, S., & Xi, Y. (2021) · Cell Regeneration · doi:10.1186/s13619-021-00082-8 · Cited by 55
Applications of Brain Organoids for Infectious Diseases
Fan, W., Christian, K. M., Song, H., & Ming, G. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167243 · Cited by 56
Tanaka, J., Senpuku, H., Ogawa, M., Yasuhara, R., Ohnuma, S., Takamatsu, K., Watanabe, T., Mabuchi, Y., Nakamura, S., Ishida, S., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-01007-6 · Cited by 53
Merits and challenges of iPSC-derived organoids for clinical applications
Xu, Z., Yang, J., Xin, X., Liu, C., Li, L., Mei, X., & Li, M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1188905 · Cited by 57
Organoids from pluripotent stem cells and human tissues: When two cultures meet each other
Artegiani, B., & Hendriks, D. F. G. (2025) · Developmental Cell · doi:10.1016/j.devcel.2025.01.005 · Cited by 54
Izzo, R., Pacella, D., Trimarco, V., Manzi, M. V., Lombardi, A., Piccinocchi, R., Gallo, P., Esposito, G., Lembo, M., Piccinocchi, G., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102345 · Cited by 53
Tailored Biosensors for Drug Screening, Efficacy Assessment, and Toxicity Evaluation
Tao, Y., Chen, L., Pan, M., Zhu, F., & Zhu, D. (2021) · ACS Sensors · doi:10.1021/acssensors.1c01600 · Cited by 49
Mechanisms of Lung Injury Induced by SARS-CoV-2 Infection
Upadhya, S. W., Rehman, J., Malik, A. B., & Chen, S. (2021) · Physiology · doi:10.1152/physiol.00033.2021 · Cited by 54
Self-citationHuman Organoids and Organs‐on‐Chips for Addressing COVID‐19 Challenges
Wang, Y., Wang, P., & Qin, J. (2022) · Advanced Science · doi:10.1002/advs.202105187 · Cited by 48
Self-citationKnyazev, E. N., Nersisyan, S. A., & Tonevitsky, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.636966 · Cited by 47
Global Literature Analysis of Organoid and Organ‐on‐Chip Research
Shoji, J., Davis, R. P., Mummery, C. L., & Krauss, S. J. K. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301067 · Cited by 52
Duarte, R. R. R., Copertino, D. C., Iñiguez, L., Marston, J. L., Bram, Y., Han, Y., Schwartz, R. E., Chen, S., Nixon, D. F., & Powell, T. R. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00356-6 · Cited by 49
Self-citationColloidal Aggregators in Biochemical SARS-CoV-2 Repurposing Screens
O’Donnell, H. R., Tummino, T. A., Bardine, C., Craik, C. S., & Shoichet, B. K. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01547 · Cited by 47
Cross-validation of SARS-CoV-2 responses in kidney organoids and clinical populations
Helms, L., Marchiano, S., Stanaway, I. B., Hsiang, T.-Y., Juliar, B. A., Saini, S., Zhao, Y. T., Khanna, A., Menon, R., Alakwaa, F., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.154882 · Cited by 47
Metadata
- Authors
- Han, Y., Duan, X., Yang, L., Nilsson-Payant, B. E., Wang, P., Duan, F., Tang, X., Yaron, T. M., Zhang, T., Uhl, S., Bram, Y., Richardson, C., Zhu, J., Zhao, Z., Redmond, D., Houghton, S., Nguyen, D.-H. T., Xu, D., Wang, X., Jessurun, J., Borczuk, A., Huang, Y., Johnson, J. L., Liu, Y., Xiang, J., Wang, H., Cantley, L. C., tenOever, B. R., Ho, D. D., Pan, F. C., Evans, T., Chen, H. J., Schwartz, R. E., & Chen, S.
- Affiliations
- Weill Cornell Medicine (US)
- Shanghai Jiao Tong University (CN)
- Icahn School of Medicine at Mount Sinai (US)
- Aaron Diamond AIDS Research Center (US)
- University of Chicago (US)
- University of Illinois Chicago (US)
- Corresponding author
- Wang, Hui
- Cantley, Lewis C.
- tenOever, Benjamin R.
- Ho, David D.
- Pan, Fong Cheng
- Evans, Todd
- Chen, Huanhuan Joyce
- Schwartz, Robert E.
- Chen, Shuibing
- ORCID
- Han, Yuling
- Duan, Xiaohua
- Yang, Liuliu
- Nilsson-Payant, Benjamin E.
- Wang, Pengfei
- Duan, Fuyu
- Tang, Xuming
- Yaron, Tomer M.
- Zhang, Tuo
- Uhl, Skyler
- Bram, Yaron
- Zhu, Jiajun
- Redmond, David
- Houghton, Sean
- Nguyen, Duc-Huy T.
- Xu, Dong
- Wang, Xing
- Jessurun, Jose
- Borczuk, Alain
- Huang, Yaoxing
- Johnson, Jared L.
- Liu, Yuru
- Xiang, Jenny
- Wang, Hui
- Cantley, Lewis C.
- tenOever, Benjamin R.
- Ho, David D.
- Pan, Fong Cheng
- Evans, Todd
- Chen, Huanhuan Joyce
- Schwartz, Robert E.
- Chen, Shuibing
- Venue
- Nature
- Published
- 2020-10-28
- Volume
- 589
- Issue
- 7841
- Pages
- 270-275
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC8034380
- OpenAlex
- W3096177766
- Cited by
- 530
- References
- 33
- Citations by year
- 2026: 35 · 2025: 51 · 2024: 67 · 2023: 94 · 2022: 120 · 2021: 155 · 2020: 7
- FWCI
- 12.35
- Type
- journal article
- Language
- en
- Update notices
- correction (2024-05-29)
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- American Diabetes Association (7-20-COVID-211)
- Icahn School of Medicine at Mount Sinai
- Nature
- National Institutes of Health
- Defense Advanced Research Projects Agency (W911NF‐16‐C‐0050)
- Weill Cornell Medical College
- Advanced Research Projects Agency
- National Cancer Institute (R00CA226353, R01CA234614)
- National Institute of Allergy and Infectious Diseases (R01AI107301)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124463, R01DK116075, R01DK119667, 1RO3DK117252, R01DK121072, DP3DK111907, R03DK117252)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- SARS-CoV-2, COVID-19 pandemic, lung organoids, colonic organoids, human pluripotent stem cells, alveolar type II cells, enterocytes, ACE2 expression, entry inhibitors, imatinib, mycophenolic acid, high-throughput drug screening, FDA-approved drugs, antiviral activity, chemokine induction, gastrointestinal manifestations of COVID-19
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Drug Treatment, Animals, Antiviral Agents, Colon, Drug Evaluation, Preclinical, Female, Humans, Lung, Male, Organoids, United States, United States Food and Drug Administration, Drug Approval, Mice, Virus Internalization, Viral Tropism, Heterografts, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
